Objectives: This study sought to investigate the prevalence and impact of acute kidney injury (AKI) in elderly patients undergoing percutaneous coronary intervention (PCI).
Acute kidney injury (AKI), mostly occurring within the first three days after contrast exposure, is a dreaded complication after percutaneous coronary intervention (PCI) and has been associated with worse outcomes and increased health care costs. 10, 11 The pathophysiology of AKI is multifaceted and comprises both ischemic and nephrotoxic injury. 12 The prevalence varies between 2% in the general population and 50% in high-risk patients such as those with diabetes mellitus, chronic kidney disease, and congestive heart failure. 10, 13, 14 Data on the prevalence and impact of AKI in elderly patients undergoing PCI is limited.
This study therefore sought to investigate the role of AKI in elderly (≥80 years) patients undergoing PCI.
2 | METHODS
| Study population
Out of 683 consecutive patients ≥80 years of age undergoing PCI at Charité-University Medicine Berlin between January 2009 and December 2014, a total of 458 patients had both baseline and peak creatinine levels available and were included in the analysis.
Patients with incomplete periprocedural creatinine measurements were excluded, as were those with preexisting end-stage chronic kidney disease requiring hemodialysis. 15 All patients received evidence-based medical care and PCI according to current guidelines and recommendations for myocardial revascularization. [16] [17] [18] Guideline-recommended strategies for prevention of AKI were applied in all patients undergoing elective or early invasive procedures with an estimated glomerular filtration rate of ≤40 mL/min/1.73 2 , and included preventive hydration with isotonic saline started approximately 12 h before PCI and continued for at least 24 h afterwards. 19, 20 Of the 458 patients, follow-up at 30 days and at 1 year was available in 361 (78.8%) and 251 (54.8%) patients. The study was approved by the local ethics committee and conducted in full conformance with the principles of the Declaration of Helsinki.
| Definitions
The primary endpoint was all-cause mortality at a median follow-up of 280 (interquartile range 22-1190) days. Major adverse cardiovascular events were defined as a composite of all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, and hospitalization for heart failure. AKI was defined as an absolute increase of serum creatinine of ≥0.5 mg/dL or a relative increase of ≥25% from baseline values within the first 72 h following administration of contrast medium. 13, [21] [22] [23] [24] In a second analysis, AKI was defined as ≥0.3 mg/dL or ≥50% increase in creatinine levels from baseline in accordance with the kidney disease improving global outcomes (KDIGO) classification. 25 Bleeding was defined as bleeding requiring red blood cell transfusion in line with the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) criteria. high levels (>median, P = 0.53). Patients with AKI were older (>90 years, P = 0.03), and more frequently presented with congestive heart failure (P < 0.001), left ventricular systolic dysfunction (P = 0.03), and non-ST segment elevation myocardial infarction (P = 0.04). C-reactive protein levels were higher in patients with as compared to those without AKI (P = 0.01, Table 1 ). Rates of AKI were 35.8% and 26.2% in patients with and without an increased amount (≥300 mL) of contrast media used (P = 0.14, Table 2 ). Medication at discharge did not differ between groups besides a lower use of renin-angiotensin system blockers in patients with AKI (P = 0.02, Table 2 ).
Patients with AKI had a longer hospital stay (9 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Table 2 ). Age >90 years (P = 0.02), congestive heart failure at presentation (P = 0.004), and C-reactive protein (P = 0.04) emerged as independent predictors of AKI (Table 3 ).
All-cause mortality at total follow-up was 20.0% and 8.4% in patients with and without AKI (P = 0.001). Kaplan-Meier survival curves for all-cause mortality according to the presence/absence of AKI are shown in Figure 1A . The occurrence of AKI was associated with an increased risk of all-cause mortality (HR 2.65, 95%CI 1.54-4.55, P < 0.001), and associations remained significant after multivariable adjustments (adjusted HR 2.41, 95%CI 1.12-5.17, P = 0.02, Table 4 ). When comparing patients with a ≤0.6 mg/dL change in creatinine levels from baseline (n = 261) with those with no creatinine increase after PCI (n = 157), patients with a ≤0.6 mg/dL change in creatinine levels had higher rates of all-cause mortality (11.9% vs 5.7%, P = 0.04) and similar rates of MACE (27.6% vs 28.7%, P = 0.82). A ≤0.6 mg/dL change in creatinine levels did not emerge as independent predictor of all-cause mortality (HR 2.15, 95%CI 1.02-4.51, P = 0.04; adjusted HR 2.30, 95%CI 0.85-6.23, P = 0.10) and MACE (HR 1.01, 95%CI
0.70-1.47, P = 0.94; adjusted HR 1.14, 95%CI 0.74-1.77, P = 0.56). patients undergoing PCI developed AKI, a complication which was significantly related to mortality and adverse cardiovascular events.
| Acute kidney injury in elderly patients undergoing PCI
Although the incidence of AKI depends on the population studied and the definition applied, 23, 27 rates of AKI observed in this elderly patient cohort are higher than the ones reported in unrestricted patients undergoing PCI given their high baseline risk. Although the majority of studies observed a relation of diabetes and hypertension with AKI, 24, 31 others-similarly to our analysisfailed to demonstrate any differences between patients with and without AKI. 29 Differences between studies may at least in part be due to various baseline patient characteristics and the numbers of patients included.
Pathophysiological mechanisms underlying the occurrence of AKI are only incompletely understood. Predisposing factors such as advanced age, diabetes mellitus, chronic kidney disease, and congestive heart failure have previously been identified among others, 13, 15, 29, 32 and direct nephrotoxicity and vasoconstrictive effects of contrast agents resulting in medullary ischemia may come into play. 33, 34 In addition, an increased risk of AKI has been observed in patients presenting with acute coronary syndromes in need for urgent coronary revascularization, and in those with hemodynamic instability and left ventricular dysfunction. 11, 15 Given the rather low proportion of patients undergoing PCI for stable coronary artery disease in this study, comparisons according to the presence or absence of acute coronary syndromes were precluded.
In our large, elderly patient cohort, advanced age (≥90 years), congestive heart failure, and C-reactive protein levels emerged as independent predictors of AKI. These findings are supported by previous studies demonstrating the relation between increased C-reactive protein levels and the risk of AKI following PCI. 35 The relation between activated inflammation and AKI in the context of coronary revascularization needs to be further elucidated, particularly as previous studies suggested that contrast agents may modulate complement activation and as AKI predisposes to infections. 36, 37 Although rates of AKI were numerically higher in patients with an increased amount of contrast media used, trends did not reach statistical significance in this patient cohort. This may be explained at least in part by the rather low number of patients included in the registry. Further, we
can not exclude that comorbidities or other variables not taken into account in this elderly high-risk patient population may partially have counterbalanced the effect of the contrast volume.
| Acute kidney injury and outcomes in elderly patients undergoing PCI
The increased length of hospital stay observed in patients who developed AKI is reflective for the associated morbidity in these patients and the substantial healthcare burden. Indeed, in-hospital complications including death, cardiopulmonary resuscitation, and concomitant infections were higher in patients with AKI, with trends observed for bleeding events. Future studies are, however, needed to specifically investigate type and impact of bleeding events according to kidney function by using established bleeding classifications in elderly patients undergoing PCI.
AKI was significantly related to all-cause mortality and rates of MACE. Whether rates of adverse cardiovascular events associated with AKI are mainly due to the increased baseline comorbidities, attributed to a progressive decline in kidney function over time, or whether there is a direct causal relationship between AKI and future adverse events remains to be determined. 31 As the adverse prognosis of AKI was not only related to mortality, but did extend to increased rates of hospitalization for heart failure, the interpretation of a combined cardiorenal dysfunction may be supported. Guidelinerecommended strategies for the prevention of AKI include preventive hydration with isotonic saline and the minimization of the amount of contrast media. 19, 20 Efforts to further reduce the incidence of AKI have yielded mixed results and mainly included the use of N-acetylcysteine and sodium bicarbonate, 38 or the administration of statins or ascorbic acid. [39] [40] [41] Our findings further strengthen the unmet clinical need for novel strategies to reduce the occurrence of AKI in high-risk patients undergoing PCI.
| Limitations
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